ZAZOVE ASSOCIATES LLC Revance Therapeutics, Inc. Transaction History

ZAZOVE ASSOCIATES LLC portfolio value:

$0
portfolio value

ZAZOVE ASSOCIATES LLC quarter portfolio value change:

+38.46%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -85.72K shares -1.67M $27 0
Q1 2022 share Decrease -38.96% -54.70K shares -2.24M $19.5 85.72K
Q3 2021 share Increase +168.84% 88.19K shares 2.36M $27.86 140.43K
Q2 2021 share 0.00% 0 shares 88K $29.64 52.23K
Q1 2021 share Increase +725.46% 45.90K shares 1.28M $27.95 52.23K
Q4 2020 share Increase 0.00% 6.32K shares 179K $28.34 6.32K